Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
INVO Bioscience (now operating as INVO Fertility) is a healthcare company specializing in advanced fertility treatment solutions. The company's flagship product, INVOcell, is the first FDA-cleared intravaginal culture (IVC) system, which allows fertilization and early embryo development to occur within the woman's body rather than in a laboratory. This "in vivo" approach provides a more natural, intimate, and cost-effective alternative to traditional in vitro fertilization (IVF). Originally a salsa distribution company, the entity transitioned into the medical technology sector via a reverse merger in 2008 and has recently expanded into operating dedicated fertility clinics and acquiring established IVF centers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Emy’s Salsa Aji Distribution Company.